MedPath

Effects of Rehabilitation Combined With a Maintenance Program Compared to Rehabilitation Alone in Post-COVID-19

Not Applicable
Recruiting
Conditions
Post-COVID-19 Syndrome
Interventions
Procedure: Rehabilitation without maintenance program
Procedure: Rehabilitation combined to a digital maintenance program
Registration Number
NCT06124625
Lead Sponsor
Schön Klinik Berchtesgadener Land
Brief Summary

Infection with SARS-CoV-2 virus leads to persistent symptoms for more than 12 weeks in 15% of cases ("post-COVID syndrome"). Symptoms like fatigue, dyspnoea, limitations in physical performance and activities, head ache, anxiety symptoms, and depression are heterogenous which limit physical health and participation in daily life activities.

In the last years, multidisciplinary rehabilitation programs showed benefits in quality of life and symptom intensity in patients with post-COVID. Therefore, rehabilitation programs are recommended for individuals with Post-COVID by official sites like the German Society of Pulmonology and the European Respiratory Society.

Own first data (published at the ERS conference 2023) revealed that one the one hand, inpatient rehabilitation is effective, however, on the other hand, it is challenging to maintain these effects after completing the program. Therefore, the aim of this study is to sustain these benefits by using a digital maintenance program following the rehabilitation program compared to usual care.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Post-COVID-syndrome (Definition WHO)
  • Entered the rehabilitation process at the Schoen Klinik Berchtesgadener Land
Exclusion Criteria
  • No internet access

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
No Rehabilitation maintenance programRehabilitation without maintenance program-
Rehabilitation maintenance programRehabilitation combined to a digital maintenance program-
Primary Outcome Measures
NameTimeMethod
Change from baseline quality of life assessed by Short-Form 12 questionnaire at week 4 and week 19Baseline, week 4, week 19

The scale of the physical and mental Health component summary score ranges from minimum 0 to maximum 100 points with higher scores indicating better quality of life

Secondary Outcome Measures
NameTimeMethod
Change from the use of health care service at week 4 and week 19Baseline, week 4, week 19

Frequency of therapeutical, medical and psychological sessions will be documented.

Change from rate of sickness at week 4 and week 19Baseline, week 4, week 19

Days of sickness will be documented.

Change from baseline exercise capacity at week 4 and week 19Baseline, week 4, week 19

1-minute sit to stand test will be performed (maximum repetitions of squats in one minute)

Change from baseline quality of life at week 4 and week 19Baseline, week 4, week 19

EQ-5D-5L questionnaire will be used.

Change from the use of medications at week 4 and week 19Baseline, week 4, week 19

Amount and kind of medication will be documented.

Change from workability at week 4 and week 19Baseline, week 4, week 19

Work ability index will be used

Change from ICF functionality at week 4 and week 19Baseline, week 4, week 19

Indicators of rehabilitation status questionnaire (IRES-3) will be used.

Change from cognition at week 4 and week 19Baseline, week 4, week 19

Cognition will be measured via the software RehaCom (by Hasomed GmbH).

Change from baseline post-COVID-related symptoms at week 4 and week 19Baseline, week 4, week 19

The number of COVID-symptoms will recorded as well as their intensity will be rated on a scale from 0 \[not relevant\] until 10 \[very severe symptom\].

Change from depression symptoms at week 4 and week 19Baseline, week 4, week 19

Patient Health Questionnaire 9 will be used. The total score ranges from 0 to 27 points with higher scores indicating worse Depression symptoms

Change from anxiety symptoms at week 4 and week 19Baseline, week 4, week 19

Generalized Anxiety Disorder Scale 7 will be used. The total score ranges from 0 to 21 points with higher scores indicating more anxiety symptoms

Change from resilience at week 4 and week 19Baseline, week 4, week 19

Resilience scale RS-13 will be used.

Change from baseline lung function at week 4 and week 19Baseline, week 4, week 19

following Parameters will be collected:Pimax

Change from baseline fatigue symptoms at week 4 and week 19Baseline, week 4, week 19

Fatigue Assessment Scale will be used

Change from baseline physical activity at week 4 and week 19Baseline, week 4, week 19

Activity will be measure in steps per day using a wearable from Polar

Change from sleep quality at week 4 and week 19Baseline, week 4, week 19

Sleep quality will be assessed by using the Pittsburgh Sleep Quality Index (total score ranges from 0 to 21 with higher scores indicating higher impairment)

Change from cognitive impairment at week 4 and week 19Baseline, week 4, week 19

Cognitive impairment will be measured by Montreal Cognitive Assessment (MoCA)

Trial Locations

Locations (1)

Schone Klinik Berchtesgadener Land

🇩🇪

Schönau Am Königssee, Germany

© Copyright 2025. All Rights Reserved by MedPath